group_id,Component_5,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_02090,1.5222866868340523,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_09233,1.300136476080958,FUN_039977-T1,Peve_00029897,Pocillopora_meandrina_HIv1___RNAseq.g7542.t1,three_way,56.55166666666666,FUN_039977-T1,Q9ULJ7,,,,,25.1,427.0,1.1e-26,124.8,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_02537,1.2007105823922528,FUN_010620-T1,Peve_00031460,Pocillopora_meandrina_HIv1___TS.g26115.t1,three_way,50.77283333333333,FUN_010620-T1,O14514,AGRB1_HUMAN,,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],Homo sapiens (Human),29.6,659.0,1.9999999999999999e-63,246.9,sp|O14514|AGRB1_HUMAN Adhesion G protein-coupled receptor B1 OS=Homo sapiens OX=9606 GN=ADGRB1 PE=1 SV=2,GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016020; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]",cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786],GO:0002376; GO:0005615; GO:0005886; GO:0007155; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0060089; GO:0061024; GO:0098542,immune system process; extracellular space; plasma membrane; cell adhesion; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; molecular transducer activity; membrane organization; defense response to other organism
OG_02226,1.17552059053586,FUN_008631-T1,Peve_00012388,Pocillopora_meandrina_HIv1___RNAseq.g14912.t1,three_way,62.56166666666666,,,,,,,,,,,,,,,,,
OG_00916,1.1080459390328137,FUN_004253-T1,Peve_00001928,Pocillopora_meandrina_HIv1___RNAseq.g11418.t1,three_way,75.71549999999999,FUN_004253-T1,Q9MA55,,,,,30.2,364.0,6e-33,143.7,sp|Q9MA55|ACBP4_ARATH Acyl-CoA-binding domain-containing protein 4 OS=Arabidopsis thaliana OX=3702 GN=ACBP4 PE=1 SV=1,,,,,,
OG_05071,1.1080329489732763,FUN_023293-T1,Peve_00003652,Pocillopora_meandrina_HIv1___RNAseq.g23035.t1,three_way,68.382,,,,,,,,,,,,,,,,,
OG_01919,1.0103597743373465,FUN_007948-T1,Peve_00044442,Pocillopora_meandrina_HIv1___RNAseq.g18135.t1,three_way,64.81733333333334,FUN_007948-T1,Q3TTY0,PLB1_MOUSE,,"Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3)",Mus musculus (Mouse),39.7,345.0,6.200000000000003e-66,253.4,"sp|Q3TTY0|PLB1_MOUSE Phospholipase B1, membrane-associated OS=Mus musculus OX=10090 GN=Plb1 PE=1 SV=2",GO:0004622; GO:0004806; GO:0016324; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344,diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; positive regulation of acrosome reaction [GO:2000344]; triglyceride catabolic process [GO:0019433],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526],calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_01656,0.9586844579293264,FUN_006826-T1,Peve_00023770,Pocillopora_meandrina_HIv1___RNAseq.g20475.t1,three_way,76.18166666666667,,,,,,,,,,,,,,,,,
OG_03269,0.9422952835688851,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_08842,0.918093792363684,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_06956,0.899711956984968,FUN_032081-T1,Peve_00039910,Pocillopora_meandrina_HIv1___RNAseq.g5227.t1,three_way,79.99466666666666,FUN_032081-T1,Q5RE98,AOFB_PONAB,,Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.7,486.0,1.1000000000000001e-130,468.4,sp|Q5RE98|AOFB_PONAB Amine oxidase [flavin-containing] B OS=Pongo abelii OX=9601 GN=MAOB PE=2 SV=3,GO:0005739; GO:0005741; GO:0008131; GO:0050660; GO:0097621,,mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_03909,0.880773760881874,FUN_015985-T1,Peve_00024008,Pocillopora_meandrina_HIv1___RNAseq.g21401.t1,three_way,57.967666666666666,,,,,,,,,,,,,,,,,
OG_02088,0.8793352854802061,FUN_008314-T1,Peve_00026747,Pocillopora_meandrina_HIv1___RNAseq.g5785.t1,three_way,57.846,,,,,,,,,,,,,,,,,
OG_01450,0.8752526782857719,FUN_005904-T1,Peve_00035815,Pocillopora_meandrina_HIv1___RNAseq.2460_t,three_way,73.63866666666667,FUN_005904-T1,P55115,,,,,42.3,239.0,1e-48,195.3,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_08967,0.8499168102756147,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_04538,0.8473299192033661,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_03108,0.8403608962373227,FUN_012405-T1,Peve_00002856,Pocillopora_meandrina_HIv1___RNAseq.g9951.t1,three_way,66.98066666666666,,,,,,,,,,,,,,,,,
OG_04514,0.8393717520999787,FUN_022047-T1,Peve_00017133,Pocillopora_meandrina_HIv1___RNAseq.g4597.t1,three_way,56.1085,FUN_022047-T1,Q8JZM8,,,,,27.0,852.0,8.8e-68,261.5,sp|Q8JZM8|MUC4_MOUSE Mucin-4 OS=Mus musculus OX=10090 GN=Muc4 PE=2 SV=2,,,,,,
OG_01620,0.8348104563319144,FUN_006729-T1,Peve_00039560,Pocillopora_meandrina_HIv1___RNAseq.g20015.t1,three_way,68.16666666666667,FUN_006729-T1,O55240,RDH5_MOUSE,,Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (Cis-retinol dehydrogenase),Mus musculus (Mouse),44.6,285.0,1.7999999999999994e-68,261.2,sp|O55240|RDH5_MOUSE Retinol dehydrogenase 5 OS=Mus musculus OX=10090 GN=Rdh5 PE=1 SV=1,GO:0001523; GO:0004745; GO:0005788; GO:0005789; GO:0007601; GO:0008202; GO:0042572; GO:0042803; GO:0044297; GO:0047023; GO:0047044; GO:0106429,retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; visual perception [GO:0007601],cell body [GO:0044297]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],"11-cis-retinol dehydrogenase [GO:0106429]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0006629; GO:0016491; GO:0050877,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process
OG_04560,0.8313864768694454,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_01636,0.829169971988291,FUN_006769-T1,Peve_00027411,Pocillopora_meandrina_HIv1___RNAseq.g20028.t1,three_way,57.7305,FUN_006769-T1,Q9Y2U8,MAN1_HUMAN,,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),Homo sapiens (Human),42.9,317.0,7.4e-55,216.9,sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446,negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446],GO:0003677,DNA binding
OG_07200,0.8274685651337294,FUN_032709-T2,Peve_00029921,Pocillopora_meandrina_HIv1___RNAseq.g29873.t1,three_way,77.85433333333333,FUN_032709-T2,F1QB54,PABPA_DANRE,,Polyadenylate-binding protein 1A (PABP-1A) (Poly(A)-binding protein 1A),Danio rerio (Zebrafish) (Brachydanio rerio),58.9,628.0,1.0999999999999999e-187,657.9,sp|F1QB54|PABPA_DANRE Polyadenylate-binding protein 1A OS=Danio rerio OX=7955 GN=pabpc1a PE=1 SV=1,GO:0003730; GO:0005634; GO:0005829; GO:0006397; GO:0006412; GO:0006417; GO:0007507; GO:0008143; GO:0008266; GO:0010494; GO:1990904,heart development [GO:0007507]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; translation [GO:0006412],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0048856,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; anatomical structure development
OG_02502,0.8251401651694051,FUN_009857-T2,Peve_00009100,Pocillopora_meandrina_HIv1___RNAseq.g24506.t1,three_way,84.31183333333333,FUN_009857-T2,Q92005,,,,,85.1,462.0,2.1999999999999998e-231,802.7,sp|Q92005|EF1A_DANRE Elongation factor 1-alpha OS=Danio rerio OX=7955 GN=eef1a PE=2 SV=1,,,,,,
OG_03911,0.8223413207028504,FUN_015990-T1,Peve_00023998,Pocillopora_meandrina_HIv1___RNAseq.g21387.t1,three_way,69.50233333333334,FUN_015990-T1,Q5BIM1,,,,,25.3,490.0,3.2e-30,135.2,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_00264,0.8195428322436619,FUN_001041-T1,Peve_00028475,Pocillopora_meandrina_HIv1___TS.g6804.t1,three_way,83.21833333333333,FUN_001041-T1,Q7Z5V6,SAXO4_HUMAN,,Stabilizer of axonemal microtubules 4 (Protein phosphatase 1 regulatory subunit 32),Homo sapiens (Human),33.2,455.0,1.0999999999999999e-62,242.3,sp|Q7Z5V6|SAXO4_HUMAN Stabilizer of axonemal microtubules 4 OS=Homo sapiens OX=9606 GN=SAXO4 PE=1 SV=1,GO:0005737; GO:0019902; GO:0030317; GO:0036064; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126],phosphatase binding [GO:0019902],GO:0005815; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,microtubule organizing center; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_07144,0.8190511614395316,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_02976,0.8171001735109678,FUN_012142-T1,Peve_00001101,Pocillopora_meandrina_HIv1___RNAseq.g23866.t1,three_way,57.71,,,,,,,,,,,,,,,,,
OG_06850,0.8134690136614172,FUN_031791-T1,Peve_00019321,Pocillopora_meandrina_HIv1___RNAseq.g5572.t1,three_way,73.44166666666666,FUN_031791-T1,K7VCB9,,,,,43.1,232.0,1e-38,161.8,sp|K7VCB9|THIM_MAIZE Hydroxyethylthiazole kinase OS=Zea mays OX=4577 GN=THIM PE=1 SV=1,,,,,,
OG_07218,0.810065983190152,FUN_032790-T1,Peve_00010373,Pocillopora_meandrina_HIv1___RNAseq.g29721.t1,three_way,55.391333333333336,FUN_032790-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),38.8,456.0,1.5999999999999999e-83,312.8,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_09036,0.8087583582094924,FUN_038637-T1,Peve_00013493,Pocillopora_meandrina_HIv1___RNAseq.g26491.t1,three_way,71.66766666666666,FUN_038637-T1,P70426,,,,,43.2,183.0,1.3999999999999998e-29,131.7,sp|P70426|RIT1_MOUSE GTP-binding protein Rit1 OS=Mus musculus OX=10090 GN=Rit1 PE=1 SV=1,,,,,,
OG_10099,0.8078938953941438,FUN_043435-T1,Peve_00028842,Pocillopora_meandrina_HIv1___RNAseq.g7834.t1,three_way,66.19233333333334,FUN_043435-T1,Q9WU63,,,,,37.7,151.0,4.9e-23,110.5,sp|Q9WU63|HEBP2_MOUSE Heme-binding protein 2 OS=Mus musculus OX=10090 GN=Hebp2 PE=1 SV=1,,,,,,
OG_00957,0.8054582438932352,FUN_004321-T1,Peve_00016506,Pocillopora_meandrina_HIv1___RNAseq.g11786.t1,three_way,75.91266666666667,FUN_004321-T1,P54357,,,,,42.0,143.0,3.7e-23,109.4,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_05726,0.805425778637492,FUN_025649-T1,Peve_00039652,Pocillopora_meandrina_HIv1___RNAseq.g23087.t2c,three_way,52.45816666666667,,,,,,,,,,,,,,,,,
OG_01853,0.8038146708799665,FUN_007804-T1,Peve_00022057,Pocillopora_meandrina_HIv1___RNAseq.g18346.t1,three_way,62.281666666666666,,,,,,,,,,,,,,,,,
OG_01177,0.8035994315858532,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_05731,0.8031164754896132,FUN_025657-T1,Peve_00042176,Pocillopora_meandrina_HIv1___RNAseq.g23075.t1,three_way,71.07683333333333,FUN_025657-T1,P17863,,,,,33.1,341.0,1.1e-45,186.4,sp|P17863|SKI_AVIES Transforming protein Ski OS=Avian erythroblastosis virus (strain Sloan-Kettering) OX=11862 GN=V-SKI PE=1 SV=1,,,,,,
OG_03845,0.8023432180059696,FUN_015318-T1,Peve_00023982,Pocillopora_meandrina_HIv1___RNAseq.g21728.t1,three_way,82.93366666666667,FUN_015318-T1,Q5QNI2,,,,,31.0,532.0,4.7999999999999997e-54,213.8,sp|Q5QNI2|NCL1_ORYSJ Sodium/calcium exchanger NCL1 OS=Oryza sativa subsp. japonica OX=39947 GN=NCL1 PE=2 SV=1,,,,,,
OG_07044,0.8021900822916291,FUN_032246-T1,Peve_00036312,Pocillopora_meandrina_HIv1___RNAseq.g24842.t1,three_way,59.7065,,,,,,,,,,,,,,,,,
OG_01261,0.7997802563210893,FUN_005023-T1,Peve_00028649,Pocillopora_meandrina_HIv1___RNAseq.g8329.t1,three_way,83.2865,FUN_005023-T1,A2BEA6,,,,,62.1,195.0,1.3e-58,228.8,sp|A2BEA6|ARI3A_DANRE AT-rich interactive domain-containing protein 3A OS=Danio rerio OX=7955 GN=arid3a PE=1 SV=1,,,,,,
OG_06757,0.7962160915238498,FUN_031570-T1,Peve_00021507,Pocillopora_meandrina_HIv1___RNAseq.g5065.t1,three_way,57.521,FUN_031570-T1,D4A218,,,,,32.0,303.0,1.1e-26,122.5,sp|D4A218|DMRT3_RAT Doublesex and mab-3 related transcription factor 3 OS=Rattus norvegicus OX=10116 GN=Dmrt3 PE=3 SV=1,,,,,,
OG_04621,0.79332281007804,FUN_022323-T1,Peve_00021645,Pocillopora_meandrina_HIv1___RNAseq.g4644.t1,three_way,86.14483333333334,,,,,,,,,,,,,,,,,
OG_01210,0.7924853954613545,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02316,0.7919632889832122,FUN_008907-T1,Peve_00027548,Pocillopora_meandrina_HIv1___RNAseq.g3972.t1,three_way,56.05233333333333,FUN_008907-T1,Q8CH34,ZP4_RAT,,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],Rattus norvegicus (Rat),27.7,332.0,4.3e-14,80.5,sp|Q8CH34|ZP4_RAT Zona pellucida sperm-binding protein 4 OS=Rattus norvegicus OX=10116 GN=Zp4 PE=2 SV=1,GO:0002922; GO:0005576; GO:0005886; GO:0007339; GO:0032190; GO:0035804; GO:0035805; GO:0042102; GO:0042802; GO:0060468; GO:0060478; GO:0062023; GO:2000344; GO:2000360,acrosomal vesicle exocytosis [GO:0060478]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of humoral immune response [GO:0002922]; positive regulation of T cell proliferation [GO:0042102]; prevention of polyspermy [GO:0060468],collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],acrosin binding [GO:0032190]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804],GO:0005198; GO:0005576; GO:0005886; GO:0016192; GO:0030312; GO:0031012,structural molecule activity; extracellular region; plasma membrane; vesicle-mediated transport; external encapsulating structure; extracellular matrix
OG_05875,0.7904554299133008,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_01520,0.7871178333397469,FUN_006266-T1,Peve_00019724,Pocillopora_meandrina_HIv1___RNAseq.g20372.t1,three_way,75.93266666666666,,,,,,,,,,,,,,,,,
OG_06132,0.7831823628464697,FUN_027938-T2,Peve_00032459,Pocillopora_meandrina_HIv1___RNAseq.g14030.t1,three_way,71.97066666666667,,,,,,,,,,,,,,,,,
OG_05874,0.782074509304843,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_02101,0.7779615719738683,FUN_008377-T1,Peve_00024686,Pocillopora_meandrina_HIv1___RNAseq.g18396.t1,three_way,53.3375,,,,,,,,,,,,,,,,,
OG_07496,0.7763137691105634,FUN_034028-T1,Peve_00043490,Pocillopora_meandrina_HIv1___RNAseq.g16571.t1,three_way,51.52466666666667,,,,,,,,,,,,,,,,,
OG_03447,0.7701747801289782,FUN_014512-T1,Peve_00032000,Pocillopora_meandrina_HIv1___TS.g27391.t1,three_way,41.315000000000005,,,,,,,,,,,,,,,,,
OG_09789,0.7663219425162557,FUN_042591-T1,Peve_00012673,Pocillopora_meandrina_HIv1___RNAseq.g16869.t1,three_way,79.75733333333334,FUN_042591-T1,Q87PP5,,,,,36.3,535.0,8.499999999999999e-92,339.7,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_06174,0.7655627854132881,FUN_028030-T1,Peve_00044201,Pocillopora_meandrina_HIv1___RNAseq.g13933.t1,three_way,44.60566666666666,,,,,,,,,,,,,,,,,
OG_09826,0.7638658258936423,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_09806,0.7638092734560061,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_07956,0.7622918273046507,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_08639,0.7612315214107497,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_00133,0.7589281543030059,FUN_000564-T1,Peve_00041880,Pocillopora_meandrina_HIv1___TS.g4968.t1,three_way,70.89666666666666,,,,,,,,,,,,,,,,,
OG_00793,0.751683565609955,FUN_003940-T1,Peve_00038457,Pocillopora_meandrina_HIv1___RNAseq.g11757.t1,three_way,58.294,FUN_003940-T1,Q6DG99,,,,,53.7,95.0,7.6e-19,96.3,sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1,,,,,,
OG_07929,0.7487015554064029,FUN_035418-T1,Peve_00039851,Pocillopora_meandrina_HIv1___RNAseq.g27566.t1,three_way,69.55066666666667,FUN_035418-T1,B8AJ09,,,,,28.2,312.0,1.7e-16,88.6,"sp|B8AJ09|BASS4_ORYSI Probable sodium/metabolite cotransporter BASS4, chloroplastic OS=Oryza sativa subsp. indica OX=39946 GN=BASS4 PE=3 SV=1",,,,,,
OG_05661,0.7484759896255566,FUN_025430-T2,Peve_00030583,Pocillopora_meandrina_HIv1___RNAseq.g13324.t1,three_way,80.823,FUN_025430-T2,Q3ZBV2,DD19A_BOVIN,,ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box protein 19A),Bos taurus (Bovine),64.6,418.0,8.7e-162,571.6,sp|Q3ZBV2|DD19A_BOVIN ATP-dependent RNA helicase DDX19A OS=Bos taurus OX=9913 GN=DDX19A PE=2 SV=1,GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016887; GO:0016973,poly(A)+ mRNA export from nucleus [GO:0016973],cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006913; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleocytoplasmic transport; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08928,0.7481047937838673,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_04618,0.74780327519067,FUN_022319-T1,Peve_00021701,Pocillopora_meandrina_HIv1___TS.g22054.t1,three_way,56.806333333333335,,,,,,,,,,,,,,,,,
OG_02484,0.7433973769252379,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_08937,0.7383779608259458,FUN_038401-T1,Peve_00000033,Pocillopora_meandrina_HIv1___RNAseq.g28276.t1,three_way,76.06083333333333,FUN_038401-T1,Q9BG91,,,,,65.5,148.0,5e-50,200.3,sp|Q9BG91|SOX9_CALJA Transcription factor SOX-9 OS=Callithrix jacchus OX=9483 GN=SOX9 PE=2 SV=1,,,,,,
OG_09075,0.7358617601397122,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_04857,0.7356349605025487,FUN_022871-T1,Peve_00012299,Pocillopora_meandrina_HIv1___RNAseq.g3616.t1,three_way,89.286,FUN_022871-T1,Q90788,NKX25_CHICK,,Homeobox protein Nkx-2.5 (cNKx-2.5) (Homeobox protein NK-2 homolog E),Gallus gallus (Chicken),52.2,159.0,1.2e-33,145.2,sp|Q90788|NKX25_CHICK Homeobox protein Nkx-2.5 OS=Gallus gallus OX=9031 GN=NKX-2.5 PE=2 SV=1,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001947; GO:0003148; GO:0003166; GO:0003168; GO:0003211; GO:0003221; GO:0003222; GO:0003228; GO:0003278; GO:0003285; GO:0003342; GO:0003350; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007512; GO:0010628; GO:0010667; GO:0010765; GO:0010832; GO:0030097; GO:0030154; GO:0030855; GO:0030878; GO:0032991; GO:0032993; GO:0042803; GO:0045666; GO:0045823; GO:0048536; GO:0050673; GO:0050679; GO:0051891; GO:0055005; GO:0055117; GO:0060037; GO:0060038; GO:0060043; GO:0060048; GO:0060261; GO:0060347; GO:0060412; GO:0060413; GO:0060928; GO:0060929; GO:0060971; GO:0061629; GO:0071772; GO:0090090; GO:1903779; GO:1904019; GO:1904036; GO:1990664,adult heart development [GO:0007512]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; bundle of His development [GO:0003166]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; response to BMP [GO:0071772]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytosol [GO:0005829]; Nkx-2.5 complex [GO:1990664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007010; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07121,0.7337389214866128,FUN_032420-T1,Peve_00041753,Pocillopora_meandrina_HIv1___RNAseq.g24395.t1,three_way,71.22583333333333,,,,,,,,,,,,,,,,,
OG_04620,0.7253695166369257,FUN_022322-T1,Peve_00021644,Pocillopora_meandrina_HIv1___RNAseq.g4643.t1,three_way,86.02233333333332,,,,,,,,,,,,,,,,,
OG_02942,0.7252603605387988,FUN_012054-T3,Peve_00004085,Pocillopora_meandrina_HIv1___RNAseq.g23646.t1,three_way,73.15266666666666,FUN_012054-T3,Q7Z020,,,,,22.2,504.0,9.3e-26,120.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_07947,0.7243672828446983,FUN_035468-T1,Peve_00012132,Pocillopora_meandrina_HIv1___TS.g14397.t1,three_way,83.6845,FUN_035468-T1,Q8BH04,PCKGM_MOUSE,,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",Mus musculus (Mouse),65.5,611.0,6.100000000000001e-248,858.2,"sp|Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Mus musculus OX=10090 GN=Pck2 PE=1 SV=1",GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0030145; GO:0032024; GO:0032496; GO:0071333; GO:0071356; GO:0071548,cellular response to glucose stimulus [GO:0071333]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; pyruvate metabolic process [GO:0006090]; response to dexamethasone [GO:0071548]; response to lipopolysaccharide [GO:0032496],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],GO:0003824; GO:0005739; GO:0005975; GO:0016829; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lyase activity; organelle
OG_07400,0.7215457485406649,FUN_033839-T1,Peve_00016490,Pocillopora_meandrina_HIv1___RNAseq.g26367.t1,three_way,53.79466666666666,,,,,,,,,,,,,,,,,
OG_02975,0.7188732448392517,FUN_012141-T1,Peve_00001102,Pocillopora_meandrina_HIv1___RNAseq.9491_t,three_way,51.589,,,,,,,,,,,,,,,,,
OG_07103,0.7170646131813914,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_09693,0.7156721328627915,FUN_041922-T1,Peve_00007867,Pocillopora_meandrina_HIv1___RNAseq.g15626.t1,three_way,82.96933333333334,FUN_041922-T1,Q5I0R4,,,,,53.6,222.0,4.2e-63,242.7,sp|Q5I0R4|CF300_XENTR Cilia- and flagella-associated protein 300 OS=Xenopus tropicalis OX=8364 GN=cfap300 PE=2 SV=1,,,,,,
OG_00643,0.7146088027400651,FUN_001887-T1,Peve_00030489,Pocillopora_meandrina_HIv1___RNAseq.g29129.t1,three_way,64.38266666666667,FUN_001887-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),40.6,286.0,1.8000000000000002e-44,181.8,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_03671,0.7134646485022301,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_07999,0.7101491625384225,FUN_035640-T1,Peve_00020462,Pocillopora_meandrina_HIv1___RNAseq.g28090.t1,three_way,58.150333333333336,FUN_035640-T1,Q58L91,FA5V_OXYSU,,Venom prothrombin activator oscutarin-C non-catalytic subunit (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Oscutarin-C non-catalytic subunit heavy chain; Oscutarin-C non-catalytic subunit light chain],Oxyuranus scutellatus (Coastal taipan),40.5,163.0,8.3e-24,113.2,sp|Q58L91|FA5V_OXYSU Venom prothrombin activator oscutarin-C non-catalytic subunit OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1,GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729,venom-mediated blood coagulation [GO:0044469],extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729],GO:0005576; GO:0005886; GO:0060089; GO:0090729; GO:0098772,extracellular region; plasma membrane; molecular transducer activity; toxin activity; molecular function regulator activity
OG_05952,0.7098866629875811,FUN_026214-T1,Peve_00004859,Pocillopora_meandrina_HIv1___TS.g18166.t1,three_way,63.017,FUN_026214-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,371.0,3.5e-20,102.4,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_05183,0.7097959095316657,FUN_023529-T1,Peve_00044316,Pocillopora_meandrina_HIv1___TS.g7657.t1,three_way,73.594,,,,,,,,,,,,,,,,,
OG_01354,0.7060280024436566,FUN_005267-T1,Peve_00003352,Pocillopora_meandrina_HIv1___RNAseq.g8154.t1,three_way,58.39033333333333,FUN_005267-T1,B5X4E0,,,,,38.4,289.0,2.6000000000000003e-44,180.6,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_00843,0.7031754231045435,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_08705,0.7016244508687627,FUN_037955-T1,Peve_00040732,Pocillopora_meandrina_HIv1___TS.g19261.t1,three_way,55.23566666666667,FUN_037955-T1,Q9PVY9,,,,,40.6,217.0,5.7000000000000006e-36,153.3,sp|Q9PVY9|FXC2A_XENLA Forkhead box protein C2-A OS=Xenopus laevis OX=8355 GN=foxc2-a PE=2 SV=1,,,,,,
OG_00246,0.7012818495769676,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_04868,0.7002100173883171,FUN_022895-T1,Peve_00001718,Pocillopora_meandrina_HIv1___RNAseq.g3694.t1,three_way,68.29366666666667,FUN_022895-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),39.7,715.0,1.4e-142,508.4,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01479,0.69970329489805,FUN_006042-T1,Peve_00017140,Pocillopora_meandrina_HIv1___RNAseq.g20180.t1,three_way,75.429,FUN_006042-T1,Q99JW2,,,,,59.5,393.0,1.2e-140,501.1,sp|Q99JW2|ACY1_MOUSE Aminoacylase-1 OS=Mus musculus OX=10090 GN=Acy1 PE=1 SV=1,,,,,,
OG_08704,0.696270973471466,FUN_037953-T1,Peve_00040733,Pocillopora_meandrina_HIv1___RNAseq.g26512.t1,three_way,50.168,FUN_037953-T1,Q91905,,,,,68.3,60.0,4.7e-18,92.8,sp|Q91905|FXI1B_XENLA Forkhead box protein I1-B OS=Xenopus laevis OX=8355 GN=foxi1-b PE=2 SV=1,,,,,,
OG_01330,0.6953036759290621,FUN_005220-T1,Peve_00035492,Pocillopora_meandrina_HIv1___TS.g19865.t1,three_way,97.09066666666666,FUN_005220-T1,Q9TTR8,,,,,73.7,266.0,5e-111,402.1,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_09531,0.6931907151779659,FUN_041609-T1,Peve_00036118,Pocillopora_meandrina_HIv1___RNAseq.g15296.t1,three_way,62.51383333333334,,,,,,,,,,,,,,,,,
OG_04450,0.6931898818180922,FUN_019023-T1,Peve_00009450,Pocillopora_meandrina_HIv1___RNAseq.g9987.t1,three_way,68.78166666666667,,,,,,,,,,,,,,,,,
OG_00948,0.6927371053510307,FUN_004307-T1,Peve_00033930,Pocillopora_meandrina_HIv1___RNAseq.g11779.t1,three_way,63.568666666666665,FUN_004307-T1,O96952,,,,,51.0,102.0,1.3e-23,111.3,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_00453,0.6922288243534894,FUN_001377-T1,Peve_00021886,Pocillopora_meandrina_HIv1___RNAseq.g2136.t1,three_way,56.78516666666667,,,,,,,,,,,,,,,,,
OG_05670,0.6878412845036486,FUN_025463-T1,Peve_00043840,Pocillopora_meandrina_HIv1___RNAseq.g13243.t1,three_way,97.54233333333332,FUN_025463-T1,Q5E9F9,PRS7_BOVIN,,26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2),Bos taurus (Bovine),92.2,434.0,7.399999999999999e-234,810.8,sp|Q5E9F9|PRS7_BOVIN 26S proteasome regulatory subunit 7 OS=Bos taurus OX=9913 GN=PSMC2 PE=2 SV=3,GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0022624; GO:0036402; GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0140657,catalytic activity; nucleus; cytosol; hydrolase activity; isomerase activity; protein catabolic process; organelle; ATP-dependent activity
OG_04600,0.6845479878787729,FUN_022285-T1,Peve_00003591,Pocillopora_meandrina_HIv1___RNAseq.g4696.t1,three_way,62.73716666666667,FUN_022285-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),69.0,58.0,3.8e-17,90.1,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02303,0.6822038430787941,FUN_008882-T1,Peve_00032041,Pocillopora_meandrina_HIv1___RNAseq.g14468.t1,three_way,62.712,FUN_008882-T1,Q32KN7,,,,,41.7,192.0,3.3e-26,120.9,sp|Q32KN7|ZC21B_BOVIN Zinc finger C2HC domain-containing protein 1B OS=Bos taurus OX=9913 GN=ZC2HC1B PE=2 SV=1,,,,,,
OG_01068,0.6813509601967959,FUN_004549-T1,Peve_00042944,Pocillopora_meandrina_HIv1___RNAseq.15379_t,three_way,64.58533333333334,FUN_004549-T1,P9WIT2,,,,,20.5,493.0,1.5e-10,69.3,"sp|P9WIT2|GULDH_MYCTO L-gulono-1,4-lactone dehydrogenase OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=MT1821 PE=3 SV=1",,,,,,
OG_04999,0.6749105350975393,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_09599,0.6740023659956285,FUN_041749-T1,Peve_00042718,Pocillopora_meandrina_HIv1___RNAseq.g15090.t1,three_way,53.022333333333336,,,,,,,,,,,,,,,,,
OG_06366,0.6733034996472547,FUN_028970-T1,Peve_00006113,Pocillopora_meandrina_HIv1___RNAseq.g25636.t1,three_way,82.70400000000001,FUN_028970-T1,P13195,HEM1_RAT,,"5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)",Rattus norvegicus (Rat),52.0,611.0,1.8e-169,597.4,"sp|P13195|HEM1_RAT 5-aminolevulinate synthase, non-specific, mitochondrial OS=Rattus norvegicus OX=10116 GN=Alas1 PE=2 SV=2",GO:0001666; GO:0003870; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0009635; GO:0010045; GO:0030170; GO:0031667; GO:0032025; GO:0032869; GO:0034698; GO:0042541; GO:0042802; GO:0045471; GO:0048034; GO:0048821; GO:0051591; GO:0070541; GO:1903412,cellular response to insulin stimulus [GO:0032869]; erythrocyte development [GO:0048821]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to platinum ion [GO:0070541]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleoplasm; mitochondrion; cytosol; transferase activity; organelle; anatomical structure development
OG_03147,0.6730473633479385,FUN_012533-T1,Peve_00034230,Pocillopora_meandrina_HIv1___RNAseq.g23954.t1,three_way,57.28066666666667,,,,,,,,,,,,,,,,,
OG_02908,0.6682387275165427,FUN_011985-T1,Peve_00000524,Pocillopora_meandrina_HIv1___RNAseq.g23714.t1,three_way,77.837,FUN_011985-T1,P21872,,,,,57.5,1039.0,0.0,1168.3,sp|P21872|PUR2_CHICK Trifunctional purine biosynthetic protein adenosine-3 OS=Gallus gallus OX=9031 GN=GART PE=1 SV=1,,,,,,
